We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$66.4B
AUM Growth
+$5.93B
(+9.8%)
Cap. Flow
-$619M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
3,510
New
779
Increased
864
Reduced
1,015
Closed
774
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$500M |
| 2 |
Arista Networks
ANET
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$271M |
| 4 |
Eli Lilly
LLY
|
+$271M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$495M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$388M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$369M |
| 5 |
Mastercard
MA
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Consumer Discretionary | 9.99% |
| 3 | Financials | 9.73% |
| 4 | Industrials | 7.81% |
| 5 | Healthcare | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Unisys
UIS
$214M
| – | – |
-42,861
| Closed | -$197K |
|
3352
Unilever
UL
$135B
| – | – |
-116,929
| Closed | -$7.83M |
|
3353
Unifirst Corp
UNF
$5.22B
| – | – |
-6,744
| Closed | -$1.17M |
|
3354
United Natural Foods
UNFI
$2.8B
| – | – |
-96,627
| Closed | -$2.65M |
|
3355
Upbound Group
UPBD
$1.12B
| – | – |
-171,218
| Closed | -$4.1M |
|
|
URG
3356
Ur-Energy
URG
$556M
| – | – |
-199,024
| Closed | -$134K |
|
3357
UroGen Pharma
URGN
$2.25B
| – | – |
-21,285
| Closed | -$235K |
|
3358
United Rentals
URI
$71.1B
| – | – |
-73,350
| Closed | -$49.1M |
|
3359
US Bancorp
USB
$99.8B
| – | – |
-13,306
| Closed | -$559K |
|
3360
United States Lime & Minerals
USLM
$3.48B
| – | – |
-18,356
| Closed | -$1.62M |
|
3361
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| – | – |
-204,269
| Closed | -$19.1M |
|
3362
US Physical Therapy
USPH
$1.23B
| – | – |
-4,953
| Closed | -$358K |
|
3363
Unitil
UTL
$967M
| – | – |
-8,049
| Closed | -$464K |
|
3364
Visteon
VC
$2.79B
| – | – |
-110,129
| Closed | -$8.55M |
|
3365
Veeco
VECO
$3.05B
| – | – |
-88,249
| Closed | -$1.77M |
|
3366
Vertex
VERX
$1.98B
| – | – |
-40,422
| Closed | -$1.42M |
|
3367
PUT
VF Corp
VFC
$5.85B
| – | – |
-300,000
| Closed | -$4.66M |
|
3368
Vipshop
VIPS
$7.47B
| – | – |
-75,343
| Closed | -$1.18M |
|
3369
Vir Biotechnology
VIR
$1.5B
| – | – |
-266,005
| Closed | -$1.72M |
|
3370
Viking Therapeutics
VKTX
$3.98B
| – | – |
-1,648,628
| Closed | -$43.4M |
|
|
3371
PUT
Viking Therapeutics
VKTX
$3.98B
| – | – |
-15,300
| Closed | -$369K |
|
3372
Vanda Pharmaceuticals
VNDA
$296M
| – | – |
-24,694
| Closed | -$113K |
|
|
VRNA
3373
PUT
DELISTED
Verona Pharma
VRNA
| – | – |
-125,000
| Closed | -$7.94M |
|
3374
Vertex Pharmaceuticals
VRTX
$133B
| – | – |
-2,264
| Closed | -$1.04M |
|
3375
VSE Corp
VSEC
$6.11B
| – | – |
-9,743
| Closed | -$1.17M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Balyasny Asset Management held 3,510 positions worth $66.4B, up 9.8% from $60.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Balyasny Asset Management's Q2 2025 filing shows 779 new, 864 increased, 1,015 reduced and 774 closed positions. Its largest new stake was Arista Networks: 3,646,977 shares worth $373M. The largest sale was iShares Core S&P 500 ETF, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
- Balyasny Asset Management's largest Q2 2025 buy was Arista Networks: 3,646,977 shares worth $373M.
- Balyasny Asset Management added most to Brown & Brown in Q2 2025, an estimated $500M increase.
- Balyasny Asset Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $495M.
- Balyasny Asset Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2025, selling an estimated $369M.
- Balyasny Asset Management's ten largest holdings make up 13% of its $66.4B portfolio in Q2 2025.
- Balyasny Asset Management opened 779 new positions and closed 774 in Q2 2025.
- Balyasny Asset Management's portfolio value rose 9.8% quarter-over-quarter to $66.4B.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.